{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:45:44Z","timestamp":1790790344637,"version":"4.1.0"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:p>Peritoneal metastases (PM) from colorectal cancer (CRC) represent a unique clinical challenge with distinct biological behavior and therapeutic implications. Although PM has traditionally been associated with poor prognosis, recent advances in diagnostics, surgical techniques, and intraperitoneal therapies have offered selected patients opportunities for prolonged survival and, in some cases, long-term disease-free status. This review discusses the pathophysiology, risk factors, diagnostic strategies, and treatment options for CRC patients with PM. The peritoneum is the second most common site of CRC metastasis after the liver, with synchronous and metachronous PM occurring at similar rates. Risk factors include right-sided colon tumors, BRAF mutations, and mucinous histology. Diagnosis relies on imaging modalities such as CT, MRI, PET\/CT, and laparoscopy, although sensitivity remains limited for small-volume disease. The peritoneal carcinomatosis index (PCI) is a critical prognostic and therapeutic decision-making tool. Cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to improve survival, particularly in well-selected patients with limited PCI and resectable disease. While the role of HIPEC remains debated following the PRODIGE 7 trial, alternative approaches such as pressurized intraperitoneal aerosol chemotherapy (PIPAC) are emerging. Systemic chemotherapy remains foundational, but response in PM can differ from parenchymal metastases due to the peritoneal\u2013plasma barrier. Overall, outcomes are most favorable when patients are managed in specialized centers by multidisciplinary teams offering individualized, biomarker-informed treatment strategies. Ongoing research into molecular predictors and innovative drug delivery methods is critical to further improving prognosis for this complex patient population.<\/jats:p>","DOI":"10.3389\/fsurg.2025.1719153","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:53:06Z","timestamp":1768413186000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["What is worth knowing about peritoneal metastases in colorectal cancer?"],"prefix":"10.3389","volume":"12","author":[{"given":"Micha\u0142","family":"Sta\u0144czak","sequence":"first","affiliation":[{"name":"Oncological Surgery Department, Medical University of Gdansk","place":["Gda\u0144sk, Poland"]},{"name":"Department of Surgical Oncology with the Subunit of Breast Cancer, Skin and Soft Tissue Surgery, Maritime Hospital PCK","place":["Gdynia, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wies\u0142aw","family":"Kruszewski","sequence":"additional","affiliation":[{"name":"Oncological Surgery Department, Medical University of Gdansk","place":["Gda\u0144sk, Poland"]},{"name":"Department of Surgical Oncology with the Subunit of Breast Cancer, Skin and Soft Tissue Surgery, Maritime Hospital PCK","place":["Gdynia, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Ciesielski","sequence":"additional","affiliation":[{"name":"Oncological Surgery Department, Medical University of Gdansk","place":["Gda\u0144sk, Poland"]},{"name":"Department of Surgical Oncology with the Subunit of Breast Cancer, Skin and Soft Tissue Surgery, Maritime Hospital PCK","place":["Gdynia, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Walczak","sequence":"additional","affiliation":[{"name":"Oncological Surgery Department, Medical University of Gdansk","place":["Gda\u0144sk, Poland"]},{"name":"Department of Surgical Oncology with the Subunit of Breast Cancer, Skin and Soft Tissue Surgery, Maritime Hospital PCK","place":["Gdynia, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Kurek","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology with the Subunit of Breast Cancer, Skin and Soft Tissue Surgery, Maritime Hospital PCK","place":["Gdynia, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Buczek","sequence":"additional","affiliation":[{"name":"Oncological Surgery Department, Medical University of Gdansk","place":["Gda\u0144sk, Poland"]},{"name":"Department of Surgical Oncology with the Subunit of Breast Cancer, Skin and Soft Tissue Surgery, Maritime Hospital PCK","place":["Gdynia, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"Szajewski","sequence":"additional","affiliation":[{"name":"Oncological Surgery Department, Medical University of Gdansk","place":["Gda\u0144sk, Poland"]},{"name":"Department of Surgical Oncology with the Subunit of Breast Cancer, Skin and Soft Tissue Surgery, Maritime Hospital PCK","place":["Gdynia, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","article-title":"The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide","volume":"156","author":"Filho","year":"2025","journal-title":"Int J Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/jjco\/hye088","article-title":"Review of a personal experience in the management of carcinomatosis and sarcomatosis","volume":"31","author":"Sugarbaker","year":"2001","journal-title":"Jpn J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1245\/s10434-021-11045-3","article-title":"Microsatellite and RAS\/RAF mutational status as prognostic factors in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"29","author":"Tonello","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3322\/caac.21749","article-title":"The contemporary management of peritoneal metastasis: a journey from the cold past of treatment futility to a warm present and a bright future","volume":"73","author":"Foster","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B7","first-page":"80","volume-title":"TNM Classification of Malignant Tumours","author":"Brieley","year":"2017"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the analysis and research in cancers of the digestive system (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1245\/s10434-025-17517-0","article-title":"A feasibility study of mass-based response drug screening to guide personalized hyperthermic intraperitoneal chemotherapy for appendiceal and colorectal adenocarcinoma with peritoneal metastasis","volume":"32","author":"Bader","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e15914","DOI":"10.15252\/emmm.202215914","article-title":"The molecular biology of peritoneal metastatic disease","volume":"15","author":"Bootsma","year":"2023","journal-title":"EMBO Mol Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-17363-0","article-title":"Peritoneal surface malignancies (PSM) consortium group. Consensus guideline for the management of colorectal cancer with peritoneal metastases","author":"Schultz","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.1245\/s10434-025-17651-9","article-title":"Great debate: hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases\u2014should it be offered?","volume":"32","author":"Foster","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1245\/s10434-025-17518-z","article-title":"National guidelines for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal malignancies: a worldwide systematic review and recommendations of strength analysis","volume":"32","author":"Tonello","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"On behalf of the ESMO guidelines committee. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"key":"B15","author":"Cervantes","year":"2025"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.ejso.2020.11.135","article-title":"Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: a nationwide study","volume":"47","author":"Lurvink","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/bjs.8679","article-title":"Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer","volume":"99","author":"Segelman","year":"2012","journal-title":"Br J Surg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"928894","DOI":"10.3389\/fonc.2022.928894","article-title":"Nomogram for prediction of peritoneal metastasis risk in colorectal cancer","volume":"12","author":"Song","year":"2022","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7896","DOI":"10.1245\/s10434-022-12097-9","article-title":"Prediction of metachronous peritoneal metastases after radical surgery for colon cancer: a scoring system obtained from an international multicenter cohort","volume":"29","author":"Pedrazzani","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.3390\/jcm11164922","article-title":"Prognostic factors of survival in patients with peritoneal metastasis from colorectal cancer","volume":"11","author":"Mendoza-Moreno","year":"2022","journal-title":"J Clin Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00018-017-2663-1","article-title":"The peritoneal \u201csoil\u201d for a cancerous \u201cseed\u201d: a comprehensive review of the pathogenesis of intraperitoneal cancer metastases","volume":"75","author":"Miku\u0142a-Pietrasik","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"7692","DOI":"10.3748\/wjg.v22.i34.7692","article-title":"Pathophysiology of colorectal peritoneal carcinomatosis: role of the peritoneum","volume":"22","author":"Lemoine","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/jcm12010103","article-title":"Development of the peritoneal metastasis: a review of backgrounds, mechanisms, treatments and prospects","volume":"12","author":"Ren","year":"2022","journal-title":"J Clin Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13045-020-00932-z","article-title":"Beyond thrombosis: the impact of tissue factor signaling in cancer","volume":"13","author":"Unruh","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3390\/cancers15051524","article-title":"The tissue factor pathway in cancer: overview and role of heparan sulfate proteoglycans","volume":"15","author":"Hassan","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"215983","DOI":"10.1016\/j.canlet.2022.215983","article-title":"Tissue factor-induced fibrinogenesis mediates cancer cell clustering and multiclonal peritoneal metastasis","volume":"553","author":"Miyazaki","year":"2023","journal-title":"Cancer Lett"},{"key":"B28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41392-024-01960-8","article-title":"Single-cell exome sequencing reveals polyclonal seeding and TRPS1 mutations in colon cancer metastasis","volume":"9","author":"Cai","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1655019","DOI":"10.3389\/fimmu.2025.1655019","article-title":"Neutrophil extracellular traps as drivers of epithelial\u2013mesenchymal transition in cancer cells","volume":"16","author":"Maddalena","year":"2025","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ccell.2023.02.001","article-title":"NETworking with cancer: the bidirectional interplay between cancer and neutrophil extracellular traps","volume":"41","author":"Adrover","year":"2023","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-025-04153-y","article-title":"Frequent mesothelial-to-mesenchymal transition in colorectal cancer contributes to an immunosuppressive microenvironment","author":"Watabe","year":"2025","journal-title":"Virchows Arch"},{"key":"B32","doi-asserted-by":"publisher","first-page":"948952","DOI":"10.3389\/fcell.2022.948952","article-title":"Peritoneal resident macrophages in tumor metastasis and immunotherapy","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.3390\/cancers15102746","article-title":"Principles of molecular utility for CMS classification in colorectal cancer management","volume":"15","author":"Rejali","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.31557\/APJCP.2025.26.9.3239","article-title":"Differences in expression of epithelial-mesenchymal transition (EMT) induction genes TGF-\u0392 pathway transition in colorectal cancer patients non-metastatic and metastatic","volume":"26","author":"Mardiah","year":"2025","journal-title":"Asian Pac J Cancer Prev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"216262","DOI":"10.1016\/j.canlet.2023.216262","article-title":"The NF\u2013Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer","volume":"567","author":"Rigillo","year":"2023","journal-title":"Cancer Lett"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2479527","DOI":"10.1080\/02656736.2025.2479527","article-title":"Impact of RAS, BRAF mutations and microsatellite status in peritoneal metastases from colorectal cancer treated with cytoreduction+HIPEC: scoping review","volume":"42","author":"Zucchini","year":"2025","journal-title":"Int J Hyperthermia"},{"key":"B37","doi-asserted-by":"publisher","first-page":"108474","DOI":"10.1016\/j.ejso.2024.108474","article-title":"Effect of RAS and BRAF mutations on peritoneal metastasis risk and cytoreductive surgery\/hyperthermic intraperitoneal chemotherapy efficacy in colorectal cancer: a systematic review and meta-analysis","volume":"50","author":"Gao","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.23922\/jarc.2022-045","article-title":"Molecular analyses in peritoneal metastasis from colorectal cancer: a review-an English version","volume":"6","author":"Kim","year":"2022","journal-title":"J Anus Rectum Colon"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/jso.25899","article-title":"Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma","volume":"121","author":"Stein","year":"2020","journal-title":"J Surg Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4251\/wjgo.v15.i1.112","article-title":"Development and validation of a nomogram for predicting metachronous peritoneal metastasis in colorectal cancer: a retrospective study","volume":"15","author":"Ban","year":"2023","journal-title":"World J Gastrointest Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"6589","DOI":"10.1245\/s10434-025-17650-w","article-title":"ASO Practice guideline series: management of colorectal peritoneal metastases","volume":"32","author":"Wach","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1007\/s00261-024-04441-2","article-title":"The role of multimodality imaging in the selection and management of patients treated with cytoreductive surgery and HIPEC","volume":"49","author":"Mercer","year":"2024","journal-title":"Abdom Radiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/jso.27979","article-title":"Imaging of peritoneal surface malignancies","volume":"130","author":"Caruso","year":"2024","journal-title":"J Surg Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/bjs.10527","article-title":"Evaluation of the peritoneal carcinomatosis index with CT and MRI","volume":"104","author":"Dohan","year":"2017","journal-title":"BJS"},{"key":"B45","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1245\/s10434-018-7005-5","article-title":"Narrow-band imaging improves detection of colorectal peritoneal metastases: a clinical study comparing advanced imaging techniques","volume":"26","author":"Sluiter","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1245\/s10434-023-13118-x","article-title":"The prognostic value of distinct histological growth patterns of colorectal peritoneal metastases: a pilot study","volume":"30","author":"El Asmar","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1245\/s10434-025-17106-1","article-title":"Repeat diagnostic laparoscopy after chemotherapy is useful in patient selection for conversion to cytoreductive surgery for initially unresectable colorectal and appendiceal peritoneal metastases: a retrospective cohort study","volume":"32","author":"Gohda","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"109720","DOI":"10.1016\/j.ejso.2025.109720","article-title":"Preoperative tumor marker elevations in colorectal cancer patients with peritoneal metastases should be used to help select patients for cytoreductive surgery","volume":"51","author":"Ghabra","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"100011","DOI":"10.1016\/j.ijgc.2024.100011","article-title":"Computed tomography-based prediction of interval cytoreduction in advanced ovarian cancer","volume":"35","author":"Cortes Garc\u00eda","year":"2025","journal-title":"IJGCS"},{"key":"B50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1515\/pp-2023-0014","article-title":"Peritoneal regression grading score (PRGS): first evidence for independent predictive and prognostic significance","volume":"8","author":"Baake","year":"2023","journal-title":"Pleura Peritoneum"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/jso.27885","article-title":"Review of 2022 PSOGI\/RENAPE consensus on HIPEC","volume":"130","author":"Kusamura","year":"2024","journal-title":"J Surg Oncol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamasurg.2023.0662","article-title":"Efficacy and safety of intraoperative hyperthermic intraperitoneal chemotherapy for locally advanced colon cancer: a phase 3 randomized clinical trial","volume":"158","author":"Arjona-S\u00e1nchez","year":"2023","journal-title":"JAMA Surg"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S1470-2045(20)30322-3","article-title":"Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP\u2013PRODIGE 15): a randomised, phase 3 study","volume":"21","author":"Go\u00e9r\u00e9","year":"2020","journal-title":"Lancet Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2468-1253(19)30239-0","article-title":"Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial","volume":"4","author":"Klaver","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"znaf112","DOI":"10.1093\/bjs\/znaf112","article-title":"Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensus","author":"Bhatt","year":"2025","journal-title":"BJS"},{"key":"B56","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/cncr.34567","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: where do we stand?","volume":"129","author":"Witmer","year":"2023","journal-title":"Cancer"},{"key":"B57","doi-asserted-by":"publisher","first-page":"101775","DOI":"10.1016\/j.suronc.2022.101775","article-title":"When and how are peritoneal metastases of colo-rectal origin treatable","volume":"43","author":"Cortes-Guiral","year":"2022","journal-title":"Surg Oncol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/SLA.0000000000006492","article-title":"Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy and liver resection is a treatment option for patients with peritoneal and liver metastases from colorectal cancer","volume":"280","author":"Dagenborg","year":"2024","journal-title":"Ann Surg"},{"key":"B59","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1245\/s10434-025-17321-w","article-title":"Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) and liver-directed therapy for synchronous peritoneal and liver metastatic colorectal cancer: a systematic review with meta-analysis","volume":"32","author":"Taqi","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/DCR.0000000000002027","article-title":"Synchronous liver resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases: a systematic review and meta-analysis","volume":"64","author":"Flood","year":"2021","journal-title":"Dis Colon Rectum"},{"key":"B61","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1470-2045(24)00660-0","article-title":"Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial","volume":"26","author":"van der Lei","year":"2025","journal-title":"Lancet Oncol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/jso.70012","article-title":"An increasing role for cytoreductive surgery in metastatic colorectal cancer\u2014national trends in the era of more effective systemic therapy","volume":"132","author":"Young","year":"2025","journal-title":"J Surg Oncol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.semcancer.2025.10.004","article-title":"Cracking the resistance code: the molecular reclassification of cancer and precision therapy strategies","volume":"117","author":"Nikanjam","year":"2025","journal-title":"Semin Cancer Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e004749","DOI":"10.1136\/jitc-2022-004749","article-title":"Resistance to systemic immune checkpoint inhibition in the peritoneal niche","volume":"10","author":"Chia","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B65","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s40265-025-02195-9","article-title":"Clinical pharmacological perspective on intraperitoneal chemotherapy","volume":"85","author":"Rietveld","year":"2025","journal-title":"Drugs"},{"key":"B66","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1245\/s10434-023-14368-5","article-title":"2022 Peritoneal surface oncology group international consensus on HIPEC regimens for peritoneal malignancies: colorectal cancer","volume":"31","author":"H\u00fcbner","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/DCR.0000000000002315","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a systematic review","volume":"65","author":"Parikh","year":"2022","journal-title":"Dis Colon Rectum"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1245\/s10434-022-13010-0","article-title":"Treatment of peritoneal metastasis with pressurized intraperitoneal aerosol chemotherapy: results from the prospective PIPAC-OPC2 study","volume":"30","author":"Graversen","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.3390\/curroncol28060447","article-title":"Pathological features and prognostication in colorectal cancer","volume":"28","author":"Chen","year":"2021","journal-title":"Curr Oncol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3946875","DOI":"10.1155\/2021\/3946875","article-title":"Prognostic value of KRAS gene mutation on survival of patients with peritoneal metastases of colorectal adenocarcinoma","volume":"2021","author":"Diez-Alonso","year":"2021","journal-title":"Int J Surg Oncol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"91","DOI":"10.23922\/jarc.2022-065","article-title":"Comparison of cytoreductive surgery and resection of isolated peritoneal metastases in patients with peritoneal metastases from colorectal cancer: a retrospective study","volume":"7","author":"Yoshida","year":"2023","journal-title":"J Anus Rectum Colon"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1245\/s10434-023-13172-5","article-title":"ASO Author reflections: peritoneal metastases of colorectal origin exhibit distinct histological growth patterns with a potential prognostic value","volume":"30","author":"El Asmar","year":"2023","journal-title":"Ann Surg Oncol"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2025.1719153\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:53:07Z","timestamp":1768413187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2025.1719153\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":72,"alternative-id":["10.3389\/fsurg.2025.1719153"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2025.1719153","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"article-number":"1719153"}}